A new study shows that using tirzepatide together with menopause hormone therapy can lead to greater weight loss in postmenopausal women who are...

TUESDAY, July 15, 2025 -- In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is...

A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, but eating more protein...

A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, but eating more protein...

New research shows that popular anti-obesity medications could do more than just help men lose weight—they may also help bring testosterone levels...

New research shows that popular anti-obesity medications could do more than just help men lose weight—they may also help bring testosterone levels...

A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...

A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...

A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and Zepbound for obesity, may...

Tirzepatide helps obese adults lose over 15% of body weight in 52 weeks-and retain much of it even six months after stopping the drug.